DMDO-Cl CAS 80841-78-7 Puritas >96.0% (GC) Olmesartan Medoxomil Factory medium
Ruifu Chemical Supple Olmesartan Medoxomil media cum High Quality:
4,5-Dimethyl-1,3-Dioxol-2-Unum (DMDO) CAS 37830-90-3
4-Chloromethyl-5-Methyl-1,3-Dioxol-2-Unum (DMDO-Cl) CAS 80841-78-7
Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylatus CAS 144689-93-0
Diethyl 2-propyl-1H-Imidazole-4,5-Dicarboxylatus CAS 144689-94-1
Trityl Olmesartan Ethyl Ester CAS 144690-33-5
Trityl Olmesartan Acid CAS 761404-85-7
N2-Trityl Olmesartan Acid CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Nomen chemicum | 4-Chloromethyl-5-methyl-1,3-dioxol-2-one |
Synonyma | DMDO-Cl |
CAS Number | 80841-78-7 |
CATTUS Number | RF-PI1871 |
Stock Status | In Stock, Productio Capacity 300 Tons/Anno |
Formulae hypotheticae | C5H5ClO3 |
M. Pondus | 148.54 |
Ferveret | 93℃/2 mmHg |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Hyalina ad Yellow Liquid |
Lepidium sativum (GC) | Retentio temporis maioris cacuminis in chromatogrammis sample correspondet ti quod normae in puritate et substantiis affinibus obtinetur. |
Puritas / Analysis Methodus | >96.0% (GC) |
Aqua (auctore Karl Fischer) | <0.50% |
immunditiam A | <1.50% |
impudicitia B | <0.50% |
immunditia C | <3.00% |
immunditia D | <4.00% |
immunditia E | <0.10% |
Index refractivus N20/D | 1.476~1.482 |
Gravitas Imprimis (20/20℃) | 1.357~1.363 |
Proton NMR Spectrum | Conformat ut Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Olmesartan Medoxomil (CAS: 144689-63-4); |
Iter Synthesis 4-Chloromethyl-5-methyl-1,3-dioxoli-2-uni.
sarcina: Fluorinated Utrem, 25kg/Drum, vel secundum exigentiam mos
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
![1](https://a395.goodao.net/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
4-Chloromethyl-5-methyl-1,3-dioxol-2-unum (DMDO-Cl) (CAS: 80841-78-7) medius est Medoxomil Olmesartan (CAS: 144689-63-4.Olmesartan Medoxomil nova est selectiva et concursus nonpeptide angiotensin II receptor adversarius princeps pressura sanguinis tractandi usus est.Olmesartan opera ligamen angiotensin II ad AT1 receptores in musculo vasculari obstruendo.Olmesartan obstringendo obligationem potius quam synthesim angiotensin II, vetat opiniones regulatorias negativas de secretione renini.Olmesartan Medoxomil in US Benicar@ deductum est, viva voce tractatum hypertensionis administratum.
-
DMDO-Cl CAS 80841-78-7 Puritas >96.0% (GC) Olmes...
-
DMDO-OH CAS 91526-18-0 Puritas >97.0% (HPLC) Azi...
-
4,5-Dimethyl-1,3-Dioxol-2-Unum (DMDO) CAS 37830-...
-
Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate...
-
N2-Trityl Olmesartan Acid CAS 752179-89-8 Purit...
-
Olmesartan Medoxomil CAS 144689-63-4 Puritas >99...
-
Olmesartan Medoxomil Intermedia CAS 144689-93.
-
Trityl Olmesartan Ethyl Ester CAS 144690-33-5 P...
-
Trityl Olmesartan Acid CAS 761404-85-7 Munditia >...
-
Trityl Olmesartan Medoxomil CAS 144690-92-6 Pur...
-
4′-Bromomethyl-2-Cyanobiphenyl (Br-OTBN) ...
-
L-Valine Methyl Ester hydrochloridum (H-Val-OMe·...
-
Losartan Potassium CAS 124750-99-8 API Factory ...
-
Candesartan Cilexetil CAS 145040-37-5 Puritas >9...
-
Telmisartan CAS 144701-48-4 Munditia >99.5% (HPLC...
-
TTBB CAS 124750-51-2 Puritas >96.0% (HPLC) Irbes...